• Life Sciences Business Outlook
  • Categories
    • AI in Healthcare
    • Clinical Trial Management
    • Drug Discovery
    • Pharma & Life Sciences
  • News
  • Insights
  • Conferences
  • Newsletter
  • Nominate
Search
Logo
Logo
Logo
posterguard
  • Home
  • Categories
      • AI in Healthcare
      • Clinical Trial Management
      • Drug Discovery
      • Pharma & Life Sciences
  • News
  • Insights
  • Conferences
  • Newsletter
  • Nominate
Logo
  • Home
  • Categories
      • AI in Healthcare
      • Clinical Trial Management
      • Drug Discovery
      • Pharma & Life Sciences
  • News
  • Insights
  • Conferences
  • Newsletter
  • Nominate
Home Tags Novartis GanLu

Tag: Novartis GanLu

Novartis’ GanLum Shows Breakthrough Phase 3 Success, Poised to Become First New Malaria Therapy in 25 Years
News

Novartis’ GanLum Shows Breakthrough Phase 3 Success, Poised to Become First New Malaria Therapy in 25 Years

Lifescience Outlook -
November 17, 2025
0
Logo

2025 © Life Sciences Business Outlook. All rights reserved.

Linkedin

Quick Links

  • About us
  • Contact us
  • Privacy Policy
  • Advertise
  • Write with us
  • Subscribe

Must Read

Agentic AI Transforms Patient Experience Across Healthcare

A New Era for AML Trial: How Genetics is Transforming Treatment Development

LabGenius Unveils Breakthrough Bispecific T-Cell Engager With Strong Tumor Response Ahead of ESMO IO 2025

Novartis’ GanLum Shows Breakthrough Phase 3 Success, Poised to Become First New Malaria Therapy in 25 Years

Popular Articles

Agentic AI Transforms Patient Experience Across Healthcare

A New Era for AML Trial: How Genetics is Transforming Treatment Development

LabGenius Unveils Breakthrough Bispecific T-Cell Engager With Strong Tumor Response Ahead of ESMO IO 2025